News
Windmoeller & Hoelscher Corp. (WHC) has acquired Addex , a supplier of blown film extrusion equipment with a special emphasis ...
Invest for Growth Success with First Half New Business Wins of $47 million and Announcement of Organic Investment of $25 millionCOLUMBUS, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Core Molding ...
MHS introduced the next evolution in micro injection molding: the new M3, a fully automated manufacturing cell designed for the high-volume production of direct-gated precision micro parts – ...
Adding screw cooling to a polycarbonate production line provides another level of process control and might just boost rate increase to boot.
Learn how to interpret gating and ejection analysis, use mold flow simulations to anticipate fill problems, and manage ...
Sean Manaea’s return has been delayed yet again. The Mets left-hander complained of left elbow discomfort following his most recent rehab outing.
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results